Woodchuck hepatitis virus (WHV) isInfection of adult humans with the hepatitis B virus (HBV) often results in acute hepatitis followed by recovery based on serological and clinical parameters (2). Progression to chronic HBV infection and associated diseases later in life, including liver cirrhosis and hepatocellular carcinoma (HCC), occur infrequently in infected immunocompetent adults, but HBV infection often persists in unvaccinated infants born to HBV carrier mothers or infected horizontally (2). Self-limited HBV infection usually involves a robust primary immune response, acute hepatitis with limited liver injury, and a substantial clearance of virus and viral antigens from the peripheral blood and liver (3, 49). Several studies indicated that the clearance of acute HBV infection relies on the development of an adequate immune response against HBV, including protective, virusneutralizing antibodies against HBV surface antigen (HBsAg), virus antigen-specific responses of T helper (Th) cells and cytolytic T lymphocytes, and the expression of antiviral cytokines in liver, such as gamma interferon and tumor necrosis factor alpha (1,9,13,20,24,26,40). In contrast, patients with established chronic HBV infection involving persistent viral replication frequently exhibit weak and inefficient humoral and cellular immune responses, resulting in continual virus replication and HBs antigenemia (1,9,13,20,24,26,40).The kinetic development of appropriate immune responses (or the failure thereof) during the earliest stages of adult and neonatal HBV infection, and their differential influence on the onset and outcome of infection, has been characterized to some extent using animal models (see below) but not humans. This is mainly because patients usually present with clinical symptoms several weeks after the HBV transmission event (except for a few rare cases involving known exposure times) (e.g., see reference 49), and chronicity is a less frequent outcome in these cases. Moreover, neonates born to chronic carrier mothers have not been subjected to detailed kinetic studies, so the contribution of the earliest immune responses promoting viral elimination versus persistence in humans is not fully understood.Woodchuck hepatitis virus (WHV) is like HBV, an orthohepadnavirus of the Eastern woodchuck (Marmota monax) with essentially identical biological properties, genomic organizations, and replicative strategies (10). Experimental infection of woodchucks with WHV is a well-accepted animal model for many aspects of the pathogenesis of human HBV infection including viral and host factors involved in the outcome of acute infection, disease progression, immune response, and antiviral therapy (22,29,33,34,43,44). Infection of neonatal or adult woodchucks with a standardized inoculum of WHV produces predictable proportions of acute, self-limited (i.e., resolved) infections versus chronic infections (6).